A listener wrote to us at the beginning of the year with a query, “I was just reading the news about the price of insulin going down to $35! Is that for everyone?”
It turns out, there is a lot of good news about the so-called “poster child” for the high cost of prescription drugs. But to say it costs $35 now is an oversimplification – and diabetes activists don’t think this fight is over.
Senior producer and self-proclaimed “insulin correspondent” Emily Pisacreta took a hard look at the recent developments.
Plus, what does the explosion of drugs like Ozempic and Wegovy have to do with the price of insulin? We break it down.
Here’s a transcript of this episode.
Send your stories and questions. Or call 724 ARM-N-LEG.
And of course we’d love for you to support this show.
Hosted on Acast. See acast.com/privacy for more information.
Mental health ‘ghost networks’ — and a ghost-buster
A $229,000 medical bill goes to court
A doctor’s love letter to ‘the People’s Hospital’
Lessons from “wrestling with a giant”
The bill looked like BS. So she took it to small claims court.
Can They Freaking Do That?!? (2023 Edition)
2022 in Review
Like pulling teeth.
The best video about health insurance, ever
Health insurance post-Roe, and a grassroots network of abortion funds
A listener asks: Could NOT having insurance be a better deal?
Quick update from Arm and a Leg HQ
California plans to make its own insulin and sell it super-cheap. Really.
Congress fixed (a piece of) Medicare. It only took a few decades.
The Medical-bill "Negotiation Lab"
The Genetic Testing ‘Bait-and-Switch’
One ER Doc’s Journey Through the Pandemic — and the Health Care System
These docs are trying to kick private equity out of their ER
Credit Where It’s Due
“The Golden Age of Older Rectums” (for investors)
Create your
podcast in
minutes
It is Free
The Modern West
Just Dumb Enough Podcast
Freakonomics Radio
The Why Files: Operation Podcast
Criminal
Jimmy Akin’s Mysterious World